Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Title
Intervention Indication Therapeutic Area Year Actions
Voxelotor for Sickle Cell Disease Voxelotor (GBT-440) Sickle cell anaemia Haematology 2017 View  |  Download
Volixibat for non-alcoholic steatohepatitis (NASH) Volixibat (SHP626; LUM-002) Non-alcoholic steatohepatitis (NASH) Hepatology 2017 View  |  Download
Viaskin Peanut – peanut allergy immunotherapy (DBV 712; EPIT Peanut) for paediatric patients aged 4-11 DBV-712 (Viaskin peanut) Peanut allergy Immunology 2017 View  |  Download
VF-001 (VitroGro ECM) for venous leg ulcer VF-001 (VitroGro ECM) Venous leg ulcers Cardiovascular System , Dermatology 2017 View  |  Download
Vestronidase alfa (UX-003) for mucopolysaccharidosis type VII (MPS 7; Sly syndrome) Vestronidase alfa (Mepsevii; rhGUS; UX003) Mucopolysaccharidosis type VII Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Venetoclax in Combination with Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukaemia – First Line Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199) Chronic lymphocytic leukaemia (CLL) Haematological Cancer and Lymphomas 2017 View  |  Download
Vemurafenib (Zelboraf) for BRAF V600 mutation positive melanoma; completely resected but at high risk of recurrence Vemurafenib (Zelboraf; PLX4032; R7204; RO5185426; PLX-4032; RG7204) Melanoma Skin Cancer 2017 View  |  Download
Veliparib in Combination with Carboplatin and Paclitaxel for Breast Cancer – First to Third Line Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664) Breast cancer Breast Cancer 2017 View  |  Download
Veliparib (ABT-888) with carboplatin and paclitaxel for advanced or metastatic non-squamous (current or former smokers) non-small cell lung cancer Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2017 View  |  Download
Upadacitinib for Adults with Moderate to Severe Active Rheumatoid Arthritis After Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) or Biologic DMARDs Failure Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate) Rheumatoid arthritis Rheumatology 2017 View  |  Download
1 2 3 12 13
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications